Interview with the CEO of ODI Pharma before their IPO

28 November 2019 - 15:18
ODI Pharma is a producer of medical cannabis products that is getting ready to do an IPO on Spotlight in Sweden. The company plans to raise SEK 25 million. IPOhub has therefore asked CEO Derek Simmross a few questions to learn more....
Spotlight (Sweden)
ODI Pharma AB
ODI Pharma is a manufacturer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are executed through wholesale distributors and pharmacies. The products are used in the treatment of multiple sclerosis, chronic pain and in chemotherapy. Business operations are mainly located in the European market, with the head office in Stockholm....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date